A detailed history of Gamma Investing LLC transactions in Alector, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 48 shares of ALEC stock, worth $236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Previous 74 35.14%
Holding current value
$236
Previous $445,000 51.01%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$4.19 - $6.23 $108 - $161
-26 Reduced 35.14%
48 $218,000
Q1 2024

Apr 05, 2024

BUY
$5.69 - $8.08 $147 - $210
26 Added 54.17%
74 $445,000
Q4 2023

Feb 01, 2024

BUY
$3.77 - $8.39 $180 - $402
48 New
48 $286,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $406M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.